Compounds > technetium tc 99m hydroxymethylene diphosphonate
Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Carcinoma, Lobular

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuah, JH; Loughran, CF1

Other Studies

1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Carcinoma, Lobular

ArticleYear
Increased renal uptake of technetium-99m HEDP in a patient with breast cancer.
    The British journal of radiology, 2010, Volume: 83, Issue:985

    Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Kidney; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Time Factors

2010